Kewaunee Scientific CORP /DE/

Kewaunee Scientific Corporation announced its first quarter fiscal year 2027 financial results, reporting a decrease in sales and net earnings compared to the prior year, though its order backlog saw an increase.

Kewaunee Scientific Corporation's recent 8-K filing details the outcomes of its Annual Meeting of Shareholders, including the re-election of Class I directors and the ratification of its independent auditors.

Kewaunee Scientific Corporation announced robust fiscal year 2026 results, showcasing nearly doubled revenue and substantial EBITDA growth, alongside strategic advancements in its integrated platform.

Kewaunee Scientific Corporation announced it will release its first quarter fiscal year 2027 financial results on September 9, 2026.

Kewaunee Scientific Corporation announced plans to release its financial results for the fourth quarter and full fiscal year ended April 30, 2026, after market close on June 23, 2026.

Kewaunee Scientific Corporation announced it will release its third quarter fiscal year 2026 financial results on March 11, 2026.

Kewaunee Scientific Corporation's Q1 FY2027 results show a decrease in net sales and net earnings compared to the prior year, though gross profit margin saw a slight increase.

Kewaunee Scientific reports a significant drop in Q3 net earnings despite overall sales growth, driven by increased tax expense and acquisition-related impacts.

Kewaunee Scientific Corporation announced significant revenue growth for the quarter and six months ended October 31, 2025, driven by the Nu Aire acquisition and international project deliveries, despite a quarterly dip in net earnings.

Kewaunee Scientific Corporation reported a significant increase in net sales and earnings for the first quarter, largely propelled by its recent acquisition of Nu Aire.

Kewaunee Scientific Corporation reports increased sales and gross profit margin for the third quarter of fiscal year 2025, driven by the acquisition of Nu Aire and improved manufacturing productivity.

Kewaunee Scientific Corporation's latest quarterly report shows a decrease in overall sales but an increase in domestic sales and gross profit margin, alongside the completion of the Nu Aire acquisition.

Kewaunee Scientific Corporation reports fiscal 2026 net earnings of $9.6 million, driven by the integration of the Nu Aire acquisition and international project deliveries.

Kewaunee Scientific Corporation reported increased sales driven by its Nu Aire acquisition but experienced a decline in net earnings for fiscal year 2025, while maintaining a strong order backlog.

Kewaunee Scientific Corporation's annual report reveals a significant increase in net earnings despite a decrease in overall sales for fiscal year 2024.

Elizabeth D. Phillips, SVP of People & Culture at Kewaunee Scientific Corp, reported transactions involving the sale of company stock and the settlement of restricted stock units.

Mandar Ranade, SVP of IT & Engineering at Kewaunee Scientific Corp, reported equity transactions on June 30, 2026, involving restricted stock units and common stock.

Ryan S. Noble, SVP of Sales & Marketing Dev at Kewaunee Scientific Corp, reported transactions involving restricted stock units and common stock.

Douglas J. Batdorff, SVP of Manufacturing Operations at Kewaunee Scientific Corp, reported significant stock transactions including the acquisition of restricted stock units and the disposal of common stock.

Donald T. Gardner III, Chief Financial Officer of Kewaunee Scientific Corp, reported significant stock transactions including the settlement of restricted stock units and the disposal of shares.

Thomas David Hull III, Director and President & CEO of Kewaunee Scientific Corp, reported significant transactions involving restricted stock units and common stock.

Kewaunee Scientific Corporation has issued its proxy statement for the upcoming Annual Meeting of Stockholders on August 26, 2026, detailing director elections, auditor ratification, and executive compensation.

Kewaunee Scientific Corporation has scheduled its 2025 Annual Meeting for August 27, 2025, where shareholders will vote on the election of two Class III directors, the ratification of Forvis Mazars, LLP as independent auditors, and the advisory approval of executive compensation.

Kewaunee Scientific Corporation has scheduled its 2025 Annual Meeting of Stockholders to address director elections, auditor ratification, and advisory votes on executive compensation, while also disclosing detailed corporate governance practices and recent financial performance metrics.

Kewaunee Scientific Corporation has filed a definitive proxy statement with the SEC.

Kewaunee Scientific Corporation will hold its annual meeting of stockholders virtually on August 28, 2024, to vote on director election, auditor ratification, executive compensation, and other business.

Anita G. Zucker's Trust has reduced its beneficial ownership in Kewaunee Scientific Corporation, selling over 40,000 shares and now holding 6.8% of the company's outstanding stock.

Minerva Advisors LLC and affiliated entities have reported beneficial ownership of 149,410 shares, representing 5.2% of Kewaunee Scientific Corporation's outstanding common stock.

Northern Trust Corporation has reported a beneficial ownership of 8.8% in Kewaunee Scientific Corp, holding 252,328 shares as of December 31, 2025.